[Epidemiology and clinical implications of carbapenemase-producing bacteria in Switzerland]

Rev Med Suisse. 2012 Apr 25;8(338):882-4, 886-9.
[Article in French]

Abstract

The emergence and global dissemination of carbapenemases represents a major threat to public health. Switzerland has not been spared; we report a case-series of four patients hospitalised in our institution colonised with carbapenemase-producing bacteria. Infections caused by carbapenemase-producing Enterobacteriaceae limit therapeutic options and increase mortality. Detection of carbapenemases is also a challenge for laboratories. It is imperative to implement stringent infection control measures in order to prevent epidemics at the hospital level.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Adult
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Community-Acquired Infections / diagnosis
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / transmission
  • Drug Resistance, Multiple, Bacterial* / genetics
  • Enterobacteriaceae / genetics
  • Enterobacteriaceae / metabolism*
  • Enterobacteriaceae / pathogenicity
  • Enterobacteriaceae / physiology
  • Enterobacteriaceae Infections / diagnosis*
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / transmission
  • Female
  • Humans
  • India
  • Male
  • Models, Biological
  • Pakistan
  • Patient Transfer
  • Prognosis
  • Switzerland
  • Travel
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Bacterial Proteins
  • beta-Lactamases
  • carbapenemase